Compounds > etoposide
Page last updated: 2024-08-23

etoposide and Liver Cirrhosis

etoposide has been researched along with Liver Cirrhosis in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (25.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Gu, Y; Liu, H; Qi, L; Wu, H; Wu, L; Xiao, L; Zhang, L; Zhang, M1
Akamatsu, N; Fujioka, Y; Fukuyama, M; Hasegawa, K; Hayashi, A; Ibaraki, T; Kokudo, N; Koya, J; Kurokawa, M; Mizuno, H; Nakamura, F; Shinozaki-Ushiku, A1
Aita, P; Boiocchi, M; Cannizzaro, R; Colussi, AM; Corona, G; Robieux, I; Sorio, R; Toffoli, G; Tumolo, S1
Furukawa, H; Hara, T; Hoshino, K; Taniguchi, T1

Other Studies

4 other study(ies) available for etoposide and Liver Cirrhosis

ArticleYear
Atractylenolide III suppresses senescence-associated secretome via inhibiting cGAS/NF-κB pathway in hepatic stellate cells.
    Clinical and experimental pharmacology & physiology, 2023, Volume: 50, Issue:4

    Topics: Cellular Senescence; Etoposide; Hepatic Stellate Cells; Humans; Liver Cirrhosis; NF-kappa B; Nucleotidyltransferases; Secretome

2023
Extranodal NK/T cell lymphoma in a living donor liver transplant recipient.
    Annals of hematology, 2017, Volume: 96, Issue:6

    Topics: Allografts; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Dexamethasone; Drug Substitution; Etoposide; Humans; Ifosfamide; Immunosuppressive Agents; Liver Cirrhosis; Liver Transplantation; Living Donors; Lymphoma, Extranodal NK-T-Cell; Methotrexate; Methylprednisolone; Mycophenolic Acid; Postoperative Complications; Remission Induction; Tacrolimus; Transplant Recipients

2017
Pharmacokinetics of oral etoposide in patients with hepatocellular carcinoma.
    Cancer chemotherapy and pharmacology, 1999, Volume: 43, Issue:4

    Topics: Administration, Oral; Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Aspartate Aminotransferases; Bilirubin; Biological Availability; Blood Proteins; Carcinoma, Hepatocellular; Chromatography, High Pressure Liquid; Etoposide; Humans; Lidocaine; Liver Cirrhosis; Liver Function Tests; Liver Neoplasms; Metabolic Clearance Rate; Middle Aged; Protein Binding; Serum Albumin; Ultrafiltration

1999
An application of recombinant human granulocyte colony-stimulating factor (rhG-CSF) in a case of hepatocellular carcinoma combined with liver cirrhosis in which leukopenia developed after chemoembolization.
    Gastroenterologia Japonica, 1991, Volume: 26, Issue:6

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Doxorubicin; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Liver Cirrhosis; Liver Neoplasms; Middle Aged; Neutropenia; Recombinant Proteins

1991